Bohui Meicui Bioengineering

Beijing Bohui Meicui Bioengineering Technology is a specialized biotechnology firm based in China and a strategic subsidiary of the publicly traded Beijing Bohui Innovation Biotechnology. The company serves as a core engineering and manufacturing platform focused on the production of plasma-derived therapeutics and vaccines. Its primary business encompasses the development of large-scale bioengineering facilities for processing human albumin, immunoglobulins, and other essential blood proteins. By integrating advanced viral vector technologies and plasma fractionation techniques, Bohui Meicui supports the group's dual-core strategy of 'blood products + vaccines' to meet domestic and international healthcare demands. The company is instrumental in managing high-standard GMP production lines that ensure the safety and efficacy of therapeutic biological products.